ImageVerifierCode 换一换
格式:PDF , 页数:7 ,大小:382.12KB ,
资源ID:2153464      下载积分:10 金币
验证码下载
登录下载
邮箱/手机:
图形码:
验证码: 获取验证码
温馨提示:
支付成功后,系统会自动生成账号(用户名为邮箱或者手机号,密码是验证码),方便下次登录下载和查询订单;
特别说明:
请自助下载,系统不会自动发送文件的哦; 如果您已付费,想二次下载,请登录后访问:我的下载记录
支付方式: 支付宝    微信支付   
验证码:   换一换

开通VIP
 

温馨提示:由于个人手机设置不同,如果发现不能下载,请复制以下地址【https://www.zixin.com.cn/docdown/2153464.html】到电脑端继续下载(重复下载【60天内】不扣币)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: 微信登录   QQ登录  

开通VIP折扣优惠下载文档

            查看会员权益                  [ 下载后找不到文档?]

填表反馈(24小时):  下载求助     关注领币    退款申请

开具发票请登录PC端进行申请


权利声明

1、咨信平台为文档C2C交易模式,即用户上传的文档直接被用户下载,收益归上传人(含作者)所有;本站仅是提供信息存储空间和展示预览,仅对用户上传内容的表现方式做保护处理,对上载内容不做任何修改或编辑。所展示的作品文档包括内容和图片全部来源于网络用户和作者上传投稿,我们不确定上传用户享有完全著作权,根据《信息网络传播权保护条例》,如果侵犯了您的版权、权益或隐私,请联系我们,核实后会尽快下架及时删除,并可随时和客服了解处理情况,尊重保护知识产权我们共同努力。
2、文档的总页数、文档格式和文档大小以系统显示为准(内容中显示的页数不一定正确),网站客服只以系统显示的页数、文件格式、文档大小作为仲裁依据,个别因单元格分列造成显示页码不一将协商解决,平台无法对文档的真实性、完整性、权威性、准确性、专业性及其观点立场做任何保证或承诺,下载前须认真查看,确认无误后再购买,务必慎重购买;若有违法违纪将进行移交司法处理,若涉侵权平台将进行基本处罚并下架。
3、本站所有内容均由用户上传,付费前请自行鉴别,如您付费,意味着您已接受本站规则且自行承担风险,本站不进行额外附加服务,虚拟产品一经售出概不退款(未进行购买下载可退充值款),文档一经付费(服务费)、不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
4、如你看到网页展示的文档有www.zixin.com.cn水印,是因预览和防盗链等技术需要对页面进行转换压缩成图而已,我们并不对上传的文档进行任何编辑或修改,文档下载后都不会有水印标识(原文档上传前个别存留的除外),下载后原文更清晰;试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓;PPT和DOC文档可被视为“模板”,允许上传人保留章节、目录结构的情况下删减部份的内容;PDF文档不管是原文档转换或图片扫描而得,本站不作要求视为允许,下载前可先查看【教您几个在下载文档中可以更好的避免被坑】。
5、本文档所展示的图片、画像、字体、音乐的版权可能需版权方额外授权,请谨慎使用;网站提供的党政主题相关内容(国旗、国徽、党徽--等)目的在于配合国家政策宣传,仅限个人学习分享使用,禁止用于任何广告和商用目的。
6、文档遇到问题,请及时联系平台进行协调解决,联系【微信客服】、【QQ客服】,若有其他问题请点击或扫码反馈【服务填表】;文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“【版权申诉】”,意见反馈和侵权处理邮箱:1219186828@qq.com;也可以拔打客服电话:4009-655-100;投诉/维权电话:18658249818。

注意事项

本文(【医脉通】2020+OSSI指南:减重和代谢手术的患者和手术选择 (英文版)pdf)为本站上传会员【老金】主动上传,咨信网仅是提供信息存储空间和展示预览,仅对用户上传内容的表现方式做保护处理,对上载内容不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知咨信网(发送邮件至1219186828@qq.com、拔打电话4009-655-100或【 微信客服】、【 QQ客服】),核实后会尽快下架及时删除,并可随时和客服了解处理情况,尊重保护知识产权我们共同努力。
温馨提示:如果因为网速或其他原因下载失败请重新下载,重复下载【60天内】不扣币。 服务填表

【医脉通】2020+OSSI指南:减重和代谢手术的患者和手术选择 (英文版)pdf

1、ORIGINAL CONTRIBUTIONSOSSI(Obesity and Metabolic Surgery Society of India)Guidelinesfor Patient and Procedure Selection for Bariatric and MetabolicSurgeryA.G.Bhasker1&A.Prasad2&P.Praveen Raj3&R.Wadhawan4&M.Khaitan5&A.J.Agarwal6&O.Tantia7&S.Baig8&R.Palaniappan9&H.V.Shivram10&S.Shah11&V.Soni12&M.Bhand

2、ari13&R.Shivahare14&S.Dhorepatil15&P.Chowbey16&M.Narwaria17&S.Shah18,19&R.Khullar20#Springer Science+Business Media,LLC,part of Springer Nature 2020AbstractBackground India isthe largesthub for bariatric andmetabolic surgeryinAsia.OSSI iscommittedtoimprove the qualityofcareand set the standards for

3、its practice in India.Methods The first draft of OSSI guidelines was prepared by the secretary,Dr.Praveen Raj under the guidance of currentPresident,Dr.Arun Prasad.All executive council members were given voting privileges,and the proposed guidelines werecirculated on email for approval of the execu

4、tive council.Guidelines were finalized after 100%agreement from all votingmembers and were also circulated among all OSSI members for their suggestions.Results OSSI upholds the BMI criteria for bariatric and metabolic surgery of 2011 IFSO-APC guidelines.In addition to this,werecognize that waist cir

5、cumference of 80 cm in females and 90 cm in males along with obesity related co-morbidities may beconsidered for surgery.In addition to standard procedures as recommended by IFSO,OSSI acknowledges the additionalprocedures,and a review of literature for these procedures is presented in the discussion

6、A.G.BA.PP.Praveen Rajdrrajgeminstitute.inR.WM.KA.J.AO.TS.BR.PH.V.SS.SV.Sonivandan_M.BR.SS.DP.CM.NS.SR.KExtended author information available on the last page of the articleObesity Surgeryhttps:/doi.org/10.1007/s11695-020-04497-1 Conclusion The burden of obesity in India is one of the highest in th

7、e world and with numbers of bariatric and metabolicprocedures rising rapidly;there is a need for country specific guidelines.The Indian population is unique in its phenotype,genotype and nutritional make up.This document enlists guidelines for surgeons and allied health practitioners as also multipl

8、eother stake-holders like primary health physicians,policy makers,insurance companies and the Indian government.Keywords ObesityandMetabolicSurgerySocietyofIndia(OSSI).Guidelines.Bariatricandmetabolicsurgery.Bodymassindex(BMI).Waistcircumference.India.AsianIndianphenotypeIntroductionHome to more tha

9、n 1.37 billion people,India today has the thirdhighest number of people suffering from obesity in the worldafterUSAandChina 1.Withrapidincrease inlevelsofobesityin India,bariatric and metabolic surgery has emerged as a validoption for treatment of clinically severe obesity 2.The Obesityand Metabolic

10、 Surgery Society of India(OSSI)was establishedin the year 2002 with eight founding members.The OSSI hadreleased its first position statement in the year 2013,whereinbariatric/metabolic surgeries were consideredas“gastrointestinalsurgeries”aimed at improving and/or treating clinically severeobesity a

11、nd associated co-morbidities.It was also stated thatbariatric/metabolic surgery is not a“cosmetic surgery”,but a“life-saving”one.Today,the society has 450 registered members practicingbariatric/metabolic surgery.In the last two decades,the num-bers of bariatric and metabolic surgical procedures have

12、grown more than tenfold in India.As per OSSI data,20,242bariatric and metabolic procedures were reportedly performedin India in 2018,and according to the IFSO global registryreport 2018,India isthe largest hub for bariatric surgery in theAsian continent 3.A guideline is a systematically developed st

13、atement to as-sist practitioner and patient decisions about appropriate healthcarefor specificclinicalcircumstances 4.Every country pre-sentsadifferentsetofhealthcarechallenges.Localacceptanceof various treatment options varies from region to region,andthere are cultural differences that must be tak

14、en into account.The burden of obesity in India is one of the highest in theworld with numbers of bariatric and metabolic proceduresrising rapidly,as the national society,we feel the need forcountry specific guidelines that will help us to set standardsand improve the quality of care for our patients

15、In the last three decades,there has been exponential eco-nomic growth in India.In addition to the changing environ-ment,Indians also have a genetic preponderance to higherbody fat percentage,and that has led to a dual epidemic ofobesity and type two diabetes 5.The Asian Indian pheno-type is also ch

16、aracterized with greater central obesity 6.Studies have shown that in Indian population there is a higherassociation of central obesity with development of type twodiabetes mellitus than that of generalized obesity 7.Alongwiththis,itisseenthatobesity-relatedmetabolicdiseasestendto develop at a much

17、lower body mass index(BMI)in theAsian population 8.Thus,in the Indian context,not onlydoweneedtohavelowerBMIcriteriaascomparedtowesterncountries,we also need to take waist circumference into ac-count for classifying obesity.While on one hand,wehavea burgeoning healthcareprob-lem in the form of obesi

18、ty and type two diabetes mellitus,onthe other hand,we are struggling with resources to battle non-communicable diseases.Unlike most western countries,Indiadoes not have state sponsored health coverage.Health insur-ance sector is dominated mainly by private insurance players.Until recently,the Indian

19、 insurance sector classified obesityand related disorders as a“cosmetic”issue and any kind oftreatment for“obesity”,and related disorders was excludedfrom insurance coverage.In October 2019,InsuranceRegulatory and Development Authority of India(IRDAI)has finally acceded to include bariatric and meta

20、bolic surgeryas a treatment option for clinically severe obesity and its re-lateddiseases.Thoughthisisawelcomechange,inabsenceofcountry specific guidelines,IRDAI has chosen to follow thearchaicNIHguidelinesforbariatricandmetabolicsurgery2.As a result of this,many deserving patients will get excluded

21、andwillnotbeabletoavailinsurancebenefitfor thetreatmentof obesity and related metabolic disorders.These guidelines recommended in this paper are based onpreviously published guidelines like NIH,JSSO,APMBSS,OSSANZ,ACMOMS,ADSS,DSS and IFSO-APC 2,912.IFSO APC guidelines of 2011 are the most recent publ

22、ishedguideline for the Asian region;however,these are now almosta decade old 9.The trends in bariatric/metabolic surgery havechangedconsiderably in the last decade,and there is an influxofnew literature.While the OSSI guidelines acknowledge theseguidelines and have borrowed from them,there was a nee

23、d toreviewthenewliteratureandproposeanupdatedcountryspecif-ic guideline for bariatric/metabolic surgery.The aim of this document is to enlist the OSSI guidelinesfor patient and procedure selection for surgeons and alliedhealth practitioners practicing bariatric and metabolic surgery.These guidelines

24、 intend to guide IRDAI and multiple otherstake-holders such as primary health physicians,specialtydoctors,patients,policy makers and the Indian government.We also acknowledge that these guidelines are not rigid rec-ommendations to be enforced in all situations and ultimatelyclinical discretion is of

25、 greatest importance.OBES SURG MethodsThe first draft of the OSSI guidelines was prepared by theOSSI Secretary,Dr.Praveen Raj under the guidance of thecurrent President,Dr.Arun Prasad.All the executive councilmembers were given voting privileges,and the proposedguidelines were circulated on email fo

26、r suggestions and sub-sequent approval of the executive council.The OSSI execu-tive council consists of the president,secretary,treasurer,jointsecretary,the past presidents of the society and two electedmembers from the North,South,East,West and Centralzonesof the country.The elected members serve a

27、s the representa-tives of their respective zones.Table 1 delineates the list ofexecutive council members who served as moderators andvoting members for the formulation of these guidelines.These guidelines were finalized after 100%agreement fromall voting members.They were also circulated among allOS

28、SI members for their valuable suggestions.This articledoes not contain any studies with human participants or ani-mals performed by any of the authors,and a statement ofinformed consent does not apply in this case.GuidelinesIndications for Bariatric/Metabolic Surgery1.Bariatric/metabolic surgery sho

29、uld be considered a treatmentoption for acceptable Indian patients with a BMI35 kg/m2,with/withoutpresenceofanyobesityrelatedco-morbidity9.2.Bariatric/metabolic surgery should be considered a treat-ment option for acceptable Indian patients with a BMI30 kg/m2,in presence of two or more obesity relat

30、ed co-morbidities 9.3.Bariatric/metabolic surgery should be considered as anon-primary treatment option for acceptable Indian pa-tients with a BMI27.5 kg/m2,with uncontrolled type2 diabetes despite optimum medical management 9.4.Any bariatric/metabolic surgery for an Indian patient withBMI 150 cm wi

31、thOAGB/MGB is ill-advised.Obes Surg.2017;27(8):21645.31.Kota SK,Ugale S,Gupta N,et al.Ileal interposition with sleevegastrectomy for treatment of type 2 diabetes mellitus.Indian JEndocrinol Metab.2012;16(4):58998.32.Kota SK,Ugale S,Gupta N,et al.Ileal interposition with divertedsleeve gastrectomy fo

32、r treatment of type 2 diabetes.Indian JEndocrinol Metab.2012;16(Suppl 2):S4589.33.Baig SJ,Priya P,Mahawar KK,et al.Weight regain after bariatricsurgery-a multicentre study of 9617 patients from Indian bariatricsurgery outcome reporting group.Obes Surg.2019;29(5):158392.34.Huang C-K.Sleeve and sleeve

33、 plus.Annals of laparoscopic andendoscopic.Surgery.2017;2:244.https:/doi.org/10.21037/ales.2017.01.10.35.Dayyeh BKA,Rajan E,Costout CJ.Endoscopic sleevegastroplasty:a potential endoscopic alternative to surgical sleevegastrectomy for treatment of obesity.Gastrointest Endosc.2013;78:5305.36.Lpez Nava

34、 G,Galvao M,Bautista-Castao I,et al.Endoscopicsleeve gastroplasty with 1-year follow-up:factors predictive ofsuccess.Endosc Int Open.2016;4:2227.37.Lpez Nava G,Galvao MP,Bautista-Castao I,et al.Endoscopicsleeve gastroplasty:how I do it?Obes Surg.2015;25:15348.38.Sharaiha RZ,Kumta NA,Saumoy M,et al.E

35、ndoscopic sleevegastroplasty significantly reduces body mass index and metaboliccomplications in obese patients.Clin Gastroenterol Hepatol.2017;15:50410.39.American Society for Gastrointestinal Endoscopy and theAmerican Society for Metabolic and Bariatric Surgery Task Forceon Endoscopic Bariatric Th

36、erapy,Ginsberg GG.A pathway toendoscopic bariatric therapies.Gastrointest Endosc.2011;74:94352.Publishers Note Springer Nature remains neutral with regard to jurisdic-tional claims in published maps and institutional affiliations.AffiliationsA.G.Bhasker1&A.Prasad2&P.Praveen Raj3&R.Wadhawan4&M.Khaita

37、n5&A.J.Agarwal6&O.Tantia7&S.Baig8&R.Palaniappan9&H.V.Shivram10&S.Shah11&V.Soni12&M.Bhandari13&R.Shivahare14&S.Dhorepatil15&P.Chowbey16&M.Narwaria17&S.Shah18,19&R.Khullar201Global Hospital,Mumbai,Apollo Group of Hospitals,Mumbai,India2Department of Surgery,Department of Surgical Gastroenterologyand D

38、epartment of Bariatric Surgery,Manipal Hospitals,NewDelhi,India3Department of Bariatric Surgery,Division of SurgicalGastroenterology,Gem Hospital&Research Centre,Coimbatore,India4Department of Minimal Access,Bariatric&GI Surgery,FortisHospital,Vasant Kunj,New Delhi,India5Bariatric and Metabolic Surg

39、ery,Global and Apollo Group ofHospitals,Mumbai,India6Sevenhills Hospital,Hinduja Healthcare,Apollo Spectre Hospitals,Criticare Hospitals,Bhakti Vedanta Hospital,Mumbai,India7ILS Hospitals,Kolkata,India8GI and Minimal Access Surgery,Belle Vue Clinic,Kolkata,India9Institute of Bariatrics,Apollo Hospit

40、als,Chennai,India10Aster CMI Hospital,Bangalore,India11Max Smart Super Speciality Hospital,Saket,New Delhi,India12Max Super Speciality Hospital,New Delhi,India13Mohak Bariatrics and Robotics Center,Indore,India14Apollo hospital,Indore,India15Shree Hospital&Diagnostic Centre Pvt.Ltd.,Pune,India16Max

41、Institute of Minimal Access,Metabolic&Bariatric Surgery,Max Super Speciality Hospital,Saket,New Delhi,India17Asian Bariatric,Ahmedabad,India18Laparo-Obeso Centre,Pune,India19Lilavati Hospital Mumbai and Hinduja Healthcare Surgical,Mumbai,India20Institute of Minimal Access,Metabolic and Bariatric Surgery,MaxSuper Speciality Hospital,Saket,New Delhi,IndiaOBES SURG

移动网页_全站_页脚广告1

关于我们      便捷服务       自信AI       AI导航        抽奖活动

©2010-2025 宁波自信网络信息技术有限公司  版权所有

客服电话:4009-655-100  投诉/维权电话:18658249818

gongan.png浙公网安备33021202000488号   

icp.png浙ICP备2021020529号-1  |  浙B2-20240490  

关注我们 :微信公众号    抖音    微博    LOFTER 

客服